Large-scale expression, purification, and characterization of an engineered prostacyclin-synthesizing enzyme with therapeutic potential.
about
Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart diseaseMolecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behaviorEngineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2.Prostacyclin therapy for pulmonary arterial hypertension.
P2860
Large-scale expression, purification, and characterization of an engineered prostacyclin-synthesizing enzyme with therapeutic potential.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Large-scale expression, purifi ...... me with therapeutic potential.
@en
Large-scale expression, purifi ...... me with therapeutic potential.
@nl
type
label
Large-scale expression, purifi ...... me with therapeutic potential.
@en
Large-scale expression, purifi ...... me with therapeutic potential.
@nl
prefLabel
Large-scale expression, purifi ...... me with therapeutic potential.
@en
Large-scale expression, purifi ...... me with therapeutic potential.
@nl
P2093
P2860
P1476
Large-scale expression, purifi ...... me with therapeutic potential.
@en
P2093
Hanjing Wu
Ke-He Ruan
Shui-Ping So
Vanessa Cervantes
P2860
P356
10.1016/J.ABB.2008.09.010
P407
P577
2008-09-22T00:00:00Z